Clinical Trial Update: Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1% [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update analyzing adherence and associated factors in teenagers using Differin Gel 0.1% for acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Differin Gel (adapalene)

Snippet

Sponsor: Galderma R&D | Conditions: Acne | Phase 4 | Status: COMPLETED